JP2017197541A5 - - Google Patents

Download PDF

Info

Publication number
JP2017197541A5
JP2017197541A5 JP2017092881A JP2017092881A JP2017197541A5 JP 2017197541 A5 JP2017197541 A5 JP 2017197541A5 JP 2017092881 A JP2017092881 A JP 2017092881A JP 2017092881 A JP2017092881 A JP 2017092881A JP 2017197541 A5 JP2017197541 A5 JP 2017197541A5
Authority
JP
Japan
Prior art keywords
delivery
pharmaceutical products
methods substantially
delivery systems
delivery methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017092881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017197541A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017197541A publication Critical patent/JP2017197541A/ja
Publication of JP2017197541A5 publication Critical patent/JP2017197541A5/ja
Pending legal-status Critical Current

Links

JP2017092881A 2011-06-10 2017-05-09 一酸化窒素(no)の加圧容器 Pending JP2017197541A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161495950P 2011-06-10 2011-06-10
US61/495,950 2011-06-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014514889A Division JP2014520113A (ja) 2011-06-10 2012-06-08 一酸化窒素(no)の加圧容器

Publications (2)

Publication Number Publication Date
JP2017197541A JP2017197541A (ja) 2017-11-02
JP2017197541A5 true JP2017197541A5 (enExample) 2018-03-01

Family

ID=47296480

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014514889A Withdrawn JP2014520113A (ja) 2011-06-10 2012-06-08 一酸化窒素(no)の加圧容器
JP2017092881A Pending JP2017197541A (ja) 2011-06-10 2017-05-09 一酸化窒素(no)の加圧容器

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014514889A Withdrawn JP2014520113A (ja) 2011-06-10 2012-06-08 一酸化窒素(no)の加圧容器

Country Status (5)

Country Link
EP (2) EP3391891A3 (enExample)
JP (2) JP2014520113A (enExample)
AU (2) AU2012267620B2 (enExample)
CA (1) CA2838829A1 (enExample)
WO (1) WO2012170843A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014071349A1 (en) * 2012-11-05 2014-05-08 Geno Llc Method of mixing gases including nitric oxide
JP6041387B2 (ja) * 2013-03-27 2016-12-07 住友精化株式会社 一酸化窒素の品質維持方法
CA3116166C (en) * 2018-10-12 2026-02-17 Sanotize Research And Development Corp. Gas-evolving compositions and container and delivery systems
JP6667817B1 (ja) * 2019-03-13 2020-03-18 住友精化株式会社 ガス組成物及びその製造方法、並びにガス製品
EP4200003A4 (en) * 2020-08-20 2025-01-01 The UAB Research Foundation NITRIC OXIDE GENERATION AND DELIVERY SYSTEMS

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5426194B2 (enExample) * 1973-09-03 1979-09-03
JP3880103B2 (ja) * 1996-07-18 2007-02-14 住友精化株式会社 医療用一酸化窒素混合ガスおよびその製造方法
US6109260A (en) * 1998-02-18 2000-08-29 Datex-Ohmeda, Inc. Nitric oxide administration device with timed pulse
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
JP3986722B2 (ja) * 2000-01-31 2007-10-03 帝人株式会社 呼吸用気体供給装置
US6345730B1 (en) * 2000-06-13 2002-02-12 Mallinckrodt Inc. Adhesively connected polymeric pressure chambers and method for making the same
US6749834B2 (en) * 2001-06-19 2004-06-15 World Precision Instruments, Inc. Methods and apparatus for therapeutic treatment of respiratory, cardiac and other pathologies
SK15942003A3 (sk) * 2001-06-21 2004-08-03 Beth Israel Deaconess Medical Center, Inc. Farmaceutická kompozícia s obsahom oxidu uhoľnatého zlepšujúca prežívanie alebo funkciu orgánov po transplantácii
US6997347B2 (en) * 2003-07-02 2006-02-14 Industrial Scientific Corporation Apparatus and method for generating calibration gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
WO2006023616A2 (en) 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US7618594B2 (en) * 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
JP3130513U (ja) * 2007-01-16 2007-03-29 株式会社旭製作所 高圧ガスカートリッジ
EP2131903B1 (en) * 2007-03-23 2018-01-24 Geno LLC Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US20110245759A1 (en) * 2008-07-30 2011-10-06 Nitric Biotherapeutics, Inc. Methods of Treating An Infection with Nitric Oxide
US8607785B2 (en) * 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
CA2781295C (en) * 2009-11-20 2018-02-13 Geno Llc Nitric oxide delivery system
ES2873089T3 (es) * 2010-02-01 2021-11-03 Vero Biotech LLC Sistema de administración de óxido nítrico
AU2011245476B2 (en) * 2010-04-26 2016-05-12 VERO Biotech LLC. Delivery of ultra pure nitric oxide (NO)

Similar Documents

Publication Publication Date Title
JP2015147774A5 (enExample)
NL301260I2 (nl) Gefapixant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
JP2018012698A5 (enExample)
JP2016028081A5 (enExample)
EP3402548C0 (en) OCCLUSION RESOLUTION IN DRUG DELIVERY DEVICES, SYSTEMS, AND METHODS
IL262432B (en) Modified nanocrystaline cellulose materials and formulations and products made therefrom
JP2016196495A5 (enExample)
JP2017214405A5 (enExample)
JP2016028092A5 (enExample)
JP2016065085A5 (enExample)
JP2018533683A5 (enExample)
ZA201804423B (en) Antiproliferative compounds, and their pharmaceutical compositions and uses
EP3359193A4 (en) NOVEL CARBOHYDRATIC ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
PL3426294T3 (pl) Postać użytkowa zawierająca przeciwciało, cyklodekstrynę i metioninę
JP2017149782A5 (enExample)
JP2019505548A5 (enExample)
JP2017528459A5 (enExample)
EP3190129A4 (en) Centrally-acting peptide derivative, and pharmaceutical composition
IL254070A0 (en) Consequences of imidazopyrimidine and imidazotriazine and a pharmaceutical preparation containing it
JP2016053220A5 (enExample)
JP2016047837A5 (enExample)
JP2017201524A5 (enExample)
JP2017531656A5 (enExample)
EP3624809A4 (en) PHARMACEUTICAL PRODUCTS, COMPOSITIONS AND RELATED PROCEDURES
EP3153163A4 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof